Article

Intertek — Stability Studies for Biopharmaceuticals

Timely and accurate evaluation of identity, strength, quality, purity and potency are key to successfully managing stability and release programs.

Timely and accurate evaluation of identity, strength, quality, purity and potency are key to successfully managing stability and release programs. With pharmaceutical stability storage capabilities in UK and Ireland, integrated with GMP analytical capabilities, Intertek scientists can design, initiate and conduct all aspects of your stability and batch release studies with specialist capabilities for biopharmaceuticals. Intertek stability studies for protein therapeutics, for example, can involve a range of technologies including; peptide fingerprinting / sequencing by LC-MS/MS, SDS-PAGE, IEF, amino acid analysis, CE, glycan analysis and more.

Intertek will be exhibiting at ICSE, Madrid in Oct 2009. Please Visit stand 8BIO40 to find out more

www.intertek.com/pharmaceutical

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content